COGNEX CORP (CGNX)

US1924221039 - Common Stock

39.79  +0.26 (+0.66%)

After market: 39.79 0 (0%)

Buy % Consensus

73

ChartMill assigns a Buy % Consensus number of 73% to CGNX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 47.46. This target is 19.29% above the current price.
CGNX was analyzed by 25 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about CGNX.
In the previous month the buy percentage consensus was at a similar level.
CGNX was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 39.7936.3646.9247.4663.00 - -8.62% 17.92% 19.29% 58.33%
Up and Down Grades
Date Firm Action Rating
2024-04-08 Citigroup Maintains Neutral -> Neutral
2024-03-19 UBS Upgrade Neutral -> Buy
2024-03-14 Truist Securities Initiate Buy
2023-11-06 Raymond James Maintains Strong Buy -> Strong Buy
2023-11-02 Stephens & Co. Maintains Equal-Weight -> Equal-Weight
2023-11-01 Needham Maintains Buy -> Buy
2023-10-10 Goldman Sachs Maintains Sell -> Sell
2023-10-03 Keybanc Initiate Sector Weight
2023-09-01 Needham Reiterate Buy -> Buy
2023-08-30 Citigroup Initiate Neutral
2023-08-07 Credit Suisse Maintains Neutral -> Neutral
2023-08-04 Morgan Stanley Maintains Underweight -> Underweight
2023-08-03 Needham Maintains Buy
2023-07-13 Credit Suisse Maintains Neutral -> Neutral
2023-06-20 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2023-05-09 Credit Suisse Maintains Neutral
2023-05-05 Needham Reiterate Buy
2023-05-05 Morgan Stanley Maintains Underweight
2023-02-23 Credit Suisse Upgrade Underperform -> Neutral
2023-02-21 Stephens & Co. Reiterate Equal-Weight
2023-02-17 Needham Maintains Buy
2023-02-01 Northcoast Research Downgrade Buy -> Neutral
2023-01-17 Morgan Stanley Downgrade Equal-Weight -> Underweight
2022-12-13 Credit Suisse Initiate Underperform
2022-11-22 Cowen & Co. Downgrade Outperform -> Market Perform
2022-11-07 Raymond James Maintains Strong Buy
2022-11-04 Needham Maintains Buy
2022-10-12 Morgan Stanley Maintains Equal-Weight
2022-09-20 Needham Maintains Buy
2022-08-12 JP Morgan Downgrade Neutral -> Underweight